CERS Q4 2023 Earnings — Cerus Corporation Revenue & Financial Results | Market Cap Arena

CERSCerus Corporation

$358M

Q4 2023 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$47M+6.2% YoY

Gross Profit

$26M55.5% margin

Operating Income

$976,0002.1% margin

Net Income

-$1M-2.8% margin

EPS (Diluted)

$-0.01

QoQ Revenue Growth

+17.6%

Cash Flow

Operating Cash Flow

-$15M

Free Cash Flow

-$15M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$198M

Total Liabilities

$144M

Stockholders' Equity

$53M

Cash & Equivalents

$12M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$47M	$44M	+6.2%
Gross Profit	$26M	$25M	+5.8%
Operating Income	$976,000	-$10M	+109.8%
Net Income	-$1M	-$14M	+90.3%

Revenue Segments

Product

$117M95%

Government Contract

$7M5%